MVC provide long-term equity and debt investment capital to fund growth, acquisitions and recapitalizations of small and middle-market
Business Model:
Revenue: $534.4M
Employees: 11-50
Address: 287 Bowman Ave.
City: Purchase
State: NY
Zip: 10577
Country: US
MVC provide long-term equity and debt investment capital to fund growth, acquisitions and recapitalizations of small and middle-market companies in a variety of industries primarily located in the U.S. MVC&s;s investments can take the form of common and preferred stock (control and non-control investments) and warrants or rights to acquire equity interests; senior and subordinated loans; or convertible securities. MVC serves as the lead investor for transactions, as well as a co-investor in companies along with other private equity sponsors.
Contact Phone:
+19147010310
Contact Email:
Listed Exchange:
NYSE
IPO Date:
7/7/2000
Ticker Symbol:
MVC
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2000 | eYak (Sonexis) | Series C | 0 |
6/2000 | SandCraft | Series B | 0 |
8/2013 | Biogenic Reagents | Series A | 9.5M |
10/2014 | AccuMED Technologies | Venture Round | - |
6/2012 | Biovation Holdings | Private Equity Round | - |
9/2008 | UAB FIMA | Venture Round | 28.1M |
7/2004 | Baltic Motors Corporation | Private Equity Round | 6M |
1/2014 | Morey’s Seafood International | Debt Financing | 8M |
10/2014 | AccuMED Technologies | Venture Round | - |
1/2014 | Morey’s Seafood International | Debt Financing | 0 |
8/2013 | Biogenic Reagents | Series A | 0 |
6/2012 | Biovation Holdings | Private Equity Round | - |
9/2008 | UAB FIMA | Venture Round | 0 |
7/2004 | Baltic Motors Corporation | Private Equity Round | 0 |
8/2000 | eYak (Sonexis) | Series C | 0 |
6/2000 | SandCraft | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|